BOLD
Boundless Bio, Inc.Company Information
- Company Name
- Boundless Bio, Inc.
- CIK
- CIK0001782303
- Category
- <br>Emerging growth company
- Ticker: Exchange
- BOLD: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- BOLD
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-07-21
- Last sale
- 2026-08-26
- Shares purchased (TTM)
- 158,598
- Shares sold (TTM)
- 50,300
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 14,966,019
- Shares outstanding
- 22,450,000
- Ownership
- 66.66%
Earnings Market Reaction
- Filing date
- 2026-08-07
- Price on filing date
- —
- 1-month reaction
- -2.08%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 20 | 17 | 18 | 15 | 15 | 15 | 27 | 40 | 31 | 25 | ||||||
| Short Term Investments | 52 | 75 | 90 | 103 | 112 | 123 | 126 | 127 | 148 | 80 | ||||||
| Prepaid Expense And Other Assets Current | 1 | 2 | 2 | 3 | 3 | 2 | 2 | 3 | 4 | 7 | ||||||
| Assets Current | 74 | 95 | 110 | 120 | 130 | 140 | 154 | 170 | 183 | 112 | ||||||
| Property Plant And Equipment Net | 0 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 2 | ||||||
| Operating Lease Right Of Use Asset | 0 | 43 | 44 | 44 | 45 | 46 | 47 | 0 | 1 | 1 | ||||||
| Restricted Cash Noncurrent | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | ||||||
| Assets | 74 | 141 | 157 | 169 | 179 | 191 | 206 | 175 | 188 | 117 | ||||||
Liabilities Current | ||||||||||||||||
| Accounts Payable And Accrued Liabilities Current | 5 | 6 | 7 | 7 | 6 | 5 | 5 | 7 | 6 | 8 | ||||||
| Employee Related Liabilities Current | 3 | 1 | 3 | 2 | 1 | 1 | 3 | 3 | 2 | 1 | ||||||
| Operating Lease Liability Current | 0 | 3 | 3 | 3 | 2 | 0 | - | 0 | 1 | 2 | ||||||
| Liabilities Current | 8 | 10 | 13 | 12 | 9 | 6 | 8 | 10 | 9 | 11 | ||||||
| Operating Lease Liability Noncurrent | 0 | 45 | 46 | 47 | 48 | 48 | 48 | - | - | - | ||||||
| Liabilities | 8 | 55 | 58 | 59 | 57 | 55 | 56 | - | - | - | ||||||
| Temporary Equity Carrying Amount Attributable To Parent | - | - | - | - | - | - | 0 | 0 | 0 | 248 | ||||||
Stockholders Equity | ||||||||||||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 363 | 360 | 358 | 357 | 356 | 354 | 352 | 350 | 348 | 10 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -0 | -0 | 0 | 0 | -0 | 0 | 0 | 0 | -0 | -0 | ||||||
| Retained Earnings Accumulated Deficit | -297 | -273 | -260 | -247 | -233 | -217 | -201 | -185 | -169 | -152 | ||||||
| Stockholders Equity | 66 | 86 | 99 | 110 | 123 | 137 | 151 | 165 | 179 | -141 | ||||||
| Liabilities And Stockholders Equity | 74 | 141 | 157 | 169 | 179 | 191 | 206 | 175 | 188 | 117 | ||||||
| Temporary Equity Par Or Stated Value Per Share | - | - | - | - | - | - | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Temporary Equity Liquidation Preference | - | - | - | - | - | - | - | - | - | 252 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Temporary Equity Shares Authorized | - | - | - | - | - | - | 0 | 0 | 0 | 287 | ||||||
| Preferred Stock Shares Authorized | 70 | 70 | 70 | 70 | 70 | 70 | 70 | 70 | 70 | 70 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Temporary Equity Shares Issued | - | - | - | - | - | - | 0 | 0 | 0 | 287 | ||||||
| Temporary Equity Shares Outstanding | - | - | - | - | - | - | 0 | 0 | 0 | 287 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 700 | 700 | 700 | 700 | 700 | 700 | 700 | 700 | 700 | 700 | ||||||
| Common Stock Shares Issued | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 1 | ||||||
| Shares Outstanding | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 1 | ||||||
Select a line item above to chart it.
Recent filings
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialBoundless Bio, Inc. (BOLD) — SEC Financial Statements & Analysis
Boundless Bio, Inc. (BOLD) is a pharmaceutical preparations company, incorporated in DE. Boundless Bio, Inc. trades on Nasdaq as: BOLD. Boundless Bio, Inc. (BOLD)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-07. Based on that filing, Boundless Bio, Inc. carries a market cap of $56.13M, a P/E ratio of -0.88x, a P/B ratio of 0.85x, an enterprise value of $35.91M, and an EV/EBITDA multiple of -0.55x. On profitability, it posts a Return on Equity (ROE) of -67.86%, a Return on Assets (ROA) of -50.56%, and a Return on Invested Capital (ROIC) of -88.46%. Per share, it reports EPS of $-2.85, diluted EPS of $-2.85, free cash flow per share of $-2.53, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of -0.59% year-over-year and EPS growth of -1.00% year-over-year. On the balance sheet, it maintains a current ratio of 9.48x, a quick ratio of 9.35x, working capital of $65.88M, a debt-to-equity ratio of 0.12x, a debt ratio of 0.11, free cash flow of $-56.73M (TTM), and net debt of $-20.21M. Figures sourced from SEC EDGAR.
- Market Cap
- $56.13M
- P/E TTM
- -0.88x
- EPS TTM
- $-2.85
- P/B TTM
- 0.85x
- ROE TTM
- -67.86%
- ROA TTM
- -50.56%
- Debt To Equity
- 0.12x
- Free Cash Flow TTM
- $-56.73M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Boundless Bio, Inc. in?
Boundless Bio, Inc. (BOLD) operates in the Pharmaceutical Preparations industry.
What exchange does BOLD trade on?
Boundless Bio, Inc. (BOLD) trades on the Nasdaq.
Where is Boundless Bio, Inc. incorporated?
Boundless Bio, Inc. is incorporated in DE.
When was Boundless Bio, Inc. (BOLD)'s most recent SEC filing?
Boundless Bio, Inc. (BOLD)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-07.
What is BOLD's market cap?
Boundless Bio, Inc. (BOLD) has a market capitalization of $56.13M as of 2026-06-30.
What is BOLD's EPS (earnings per share)?
Boundless Bio, Inc. (BOLD)'s trailing twelve month EPS is $-2.85 as of 2026-06-30.
What is BOLD's ROE (return on equity)?
Boundless Bio, Inc. (BOLD)'s trailing twelve month Return on Equity (ROE) is -67.86% as of 2026-06-30.
What is BOLD's ROA (return on assets)?
Boundless Bio, Inc. (BOLD)'s trailing twelve month Return on Assets (ROA) is -50.56% as of 2026-06-30.
What is BOLD's ROIC (return on invested capital)?
Boundless Bio, Inc. (BOLD)'s trailing twelve month Return on Invested Capital (ROIC) is -88.46% as of 2026-06-30.
What is BOLD's EV/EBITDA?
Boundless Bio, Inc. (BOLD)'s trailing twelve month EV/EBITDA is -0.55x as of 2026-06-30.